三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图12.UBT251注射液临床进展、及优势
图12.UBT251注射液临床进展、及优势
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:2416KB
图片尺寸:2338*1817
同报告图片
/
4
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
所属报告:
联邦制药(3933.HK)-港股公司研究报告:UBT251海外授权彰显研发成果创新管线打开成长天花板-250801(30页).pdf
打包全文图表
相关数据
高压压铸工艺:铝液浇筑、压力注射、产品成型及脱模
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
收藏
行业数据
2025-10-10
原图定位
查看详情
国内丙泊酚乳状注射液销售额(亿元)
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
收藏
行业数据
2025-09-30
原图定位
查看详情
2019-2023年国内地佐辛注射液销售额(亿元)
fCDlubTku70gfCDplIDllK7pop3vvIjkur/lhYPvvIkgfAp8IC0tLS0gfCAtLS0tLS0tLS0tLS0tLSB8CnwgMjAxOSB8IDcwLjY0ICAgICAgICAgIHwKfCAyMDIwIHwgNzQuMDAgICAgICAgICAgfAp8IDIwMjEgfCA3Ny4yMyAgICAgICAgICB8CnwgMjAyMiB8IDY3LjUzICAgICAgICAgIHwKfCAyMDIzIHwgNTMuODYgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5pGp54a15Yy76I2v5pWw5o2u5bqT44CB5pGp54a15ZKo6K+i
收藏
行业数据
2025-09-30
原图定位
查看详情
UBT251国内销售、海外销售预计
<|begin_of_box|>| 项目 | 单位 | 2025E | 2026E | 2027E | 2028E | 2029E | 2030E | 2031E | 2032E | 2033E | 2034E | 2035E |
|------|------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| **国内** | | | | | | | | | | | | |
| 人口数（20岁-80岁） | 亿人 | 10.63 | 10.66 | 10.69 | 10.72 | 10.74 | 10.76 | 10.78 | 10.80 | 10.81 | 10.81 | 10.80 |
| 肥胖率 | % | 17.30% | 17.40% | 17.50% | 17.60% | 17.70% | 17.80% | 17.90% | 18.00% | 18.10% | 18.20% | 18.30% |
| 减重潜在患者人数 | 亿人 | 1.84 | 1.86 | 1.87 | 1.89 | 1.90 | 1.92 | 1.93 | 1.94 | 1.96 | 1.97 | 1.98 |
| yoy | % | - | 0.85% | 0.85% | 0.86% | 0.79% | 0.74% | 0.74% | 0.73% | 0.62% | 0.56% | 0.43% |
| 预计渗透率 | % | 12.00% | 13.00% | 13.00% | 14.00% | 14.00% | 15.00% | 15.00% | 16.00% | 16.00% | 17.00% | 17.00% |
| 减重患者群 | 百万人 | 22.07 | 24.12 | 24.32 | 26.42 | 26.62 | 28.74 | 28.95 | 31.11 | 31.30 | 33.44 | 33.58 |
| GLP-1药物占比 | % | 50.00% | 51.00% | 54.00% | 56.00% | 59.00% | 62.00% | 65.00% | 65.00% | 65.00% | 65.00% | 65.00% |
| GLP-1减重患者群 | 百万人 | 11.04 | 12.30 | 13.13 | 14.79 | 15.71 | 17.82 | 18.82 | 20.22 | 20.34 | 21.74 | 21.83 |
| yoy | % | - | 11.44% | 6.78% | 12.64% | 6.19% | 13.43% | 5.62% | 7.44% | 0.62% | 6.84% | 0.43% |
| 平均治疗时长/月 | - | 4 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 5 | 5 | 5 | 5 | 5 |
| 糖尿病患病率 | % | 11.10% | 11.20% | 11.30% | 11.40% | 11.50% | 11.60% | 11.70% | 11.80% | 11.90% | 12.00% | 12.10% |
| 患病人数 | 百万人 | 118.03 | 119.41 | 120.80 | 122.22 | 123.56 | 124.85 | 126.16 | 127.45 | 128.61 | 129.70 | 130.62 |
| yoy | % | - | 1.17% | 1.17% | 1.17% | 1.10% | 1.05% | 1.04% | 1.02% | 0.91% | 0.85% | 0.71% |
| 诊疗率 | % | 30% | 31% | 32% | 34% | 35% | 36% | 38% | 39% | 41% | 43% | 44% |
| 糖尿病用药患者人数 | 百万人 | 35.41 | 37.02 | 38.66 | 41.55 | 43.25 | 44.95 | 47.94 | 49.70 | 52.73 | 55.77 | 57.47 |
| GLP-1产品市占率 | % | 4.00% | 4.00% | 5.00% | 5.00% | 6.00% | 6.00% | 7.00% | 8.00% | 9.00% | 9.00% | 10.00% |
| GLP-1降糖患者群 | 百万人 | 1.42 | 1.48 | 1.93 | 2.08 | 2.59 | 2.70 | 3.36 | 3.98 | 4.75 | 5.02 | 5.75 |
| yoy | % | - | 4.54% | 30.54% | 7.49% | 24.89% | 3.93% | 24.43% | 18.49% | 19.34% | 5.77% | 14.51% |
| 平均治疗时长/月 | - | 7 | 8 | 8 | 8 | 9 | 10 | 10 | 10 | 10 | 10 | 10 |
| 完整年用药患者群 | 百万人 | 12.45 | 13.78 | 15.07 | 16.87 | 18.30 | 20.51 | 22.17 | 24.20 | 25.09 | 26.76 | 27.58 |
| UBT251市占率假设 | % | - | - | - | 1.0% | 2.5% | 3.5% | 5.5% | 3.0% | 2.0% | 2.0% | 1.0% |
| UBT251用药潜在患者群 | 百万人 | - | - | - | 16.9 | 18.3 | 20.5 | 22.2 | 24.2 | 25.1 | 26.8 | 27.6 |
| UBT251用药患者群 | 百万人 | - | - | - | 0.17 | 0.46 | 0.72 | 1.22 | 0.73 | 0.50 | 0.54 | 0.28 |
| 单患者用药价格 | 元/年 | - | - | - | 9350 | 9070 | 8797 | 8533 | 8107 | 7701 | 7316 | 6951 |
| yoy | % | - | - | - | - | -3.00% | -3.00% | -3.00% | -5.00% | -5.00% | -5.00% | -5.00% |
| 风险调整系数 | % | 50% | 50% | 50% | 50% | 50% | 50% | 50% | 50% | 50% | 50% | 50% |
| UBT251预计国内销售额 | 亿元 | - | - | 7.89 | 20.75 | 31.58 | 52.04 | 29.42 | 19.32 | 19.58 | 9.58 |
| yoy | % | - | - | - | 163.09% | 52.20% | 64.76% | -43.46% | -34.33% | 1.31% | -51.04% |
| **全球（除中国）** | | | | | | | | | | | | |
| 人口数（20岁-80岁） | 亿人 | 41.8 | 41.7 | 41.7 | 41.7 | 41.7 | 41.6 | 41.6 | 41.6 | 41.6 | 41.6 | 41.6 |
| 肥胖率 | % | 17.30% | 17.40% | 17.50% | 17.60% | 17.70% | 17.80% | 17.90% | 18.00% | 18.10% | 18.20% | 18.30% |
| 减重潜在患者人数 | 亿人 | 7.23 | 7.26 | 7.30 | 7.34 | 7.37 | 7.41 | 7.45 | 7.49 | 7.53 | 7.57 | 7.61 |
| yoy | % | - | 0.51% | 0.51% | 0.50% | 0.51% | 0.52% | 0.52% | 0.51% | 0.54% | 0.55% | 0.58% |
| 预计渗透率 | % | 12.00% | 13.00% | 13.00% | 14.00% | 14.00% | 15.00% | 15.00% | 16.00% | 16.00% | 17.00% | 17.00% |
| 减重患者群 | 亿人 | 0.87 | 0.94 | 0.95 | 1.03 | 1.03 | 1.11 | 1.12 | 1.20 | 1.20 | 1.29 | 1.29 |
| GLP-1药物占比 | % | 55% | 57% | 59% | 61% | 63% | 65% | 67% | 69% | 71% | 73% | 75% |
| GLP-1减重患者群 | 亿人 | 0.48 | 0.54 | 0.56 | 0.63 | 0.65 | 0.72 | 0.75 | 0.83 | 0.86 | 0.94 | 0.97 |
| yoy | % | - | 12.84% | 4.03% | 11.90% | 3.81% | 11.12% | 3.61% | 10.42% | 3.45% | 9.84% | 3.34% |
| 平均治疗时长/月 | - | 4 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 5 | 5 | 5 | 5 | 5 |
| 糖尿病患病率 | % | 11.10% | 11.40% | 11.60% | 11.70% | 11.90% | 12.20% | 12.40% | 12.70% | 12.80% | 13.10% | 13.30% |
| 患病人数 | 亿人 | 4.64 | 4.76 | 4.84 | 4.88 | 4.96 | 5.08 | 5.16 | 5.28 | 5.32 | 5.45 | 5.53 |
| yoy | % | - | 2.63% | 1.68% | 0.79% | 1.65% | 2.47% | 1.59% | 2.37% | 0.77% | 2.34% | 1.56% |
| 诊疗率 | % | 30% | 31% | 32% | 34% | 35% | 36% | 38% | 39% | 41% | 43% | 44% |
| 糖尿病用药患者人数 | 亿人 | 1.39 | 1.48 | 1.55 | 1.66 | 1.73 | 1.83 | 1.96| 2.06 | 2.18 | 2.34 | 2.43 |
| GLP-1产品市占率 | % | 4.00% | 4.00% | 5.00% | 5.00% | 6.00% | 6.00% | 7.00% | 8.00% | 9.00% | 9.00% | 10.00% |
| GLP-1降糖患者群 | 亿人 | 0.06 | 0.06 | 0.08 | 0.08 | 0.10 | 0.11 | 0.14 | 0.16 | 0.20 | 0.21 | 0.24 |
| yoy | % | - | 0.06 | 0.31 | 0.07 | 0.26 | 0.05 | 0.25 | 0.20 | 0.19 | 0.07 | 0.15 |
| 平均治疗时长/月 | - | 7 | 8 | 8 | 8 | 9 | 10 | 10 | 10 | 10 | 10 | 10 |
| 完整年用药患者群 | 亿人 | 0.53 | 0.60 | 0.64 | 0.71 | 0.75 | 0.83 | 0.89 | 0.99 | 1.05 | 1.15 | 1.21 |
| UBT251市占率假设 | % | - | - | - | 0.5% | 1.0% | 2.5% | 4.5% | 3.5% | 2.0% | 2.0% | 1.0% |
| UBT251用药潜在患者群 | 亿人 | - | - | - | 0.7 | 0.8 | 0.8 | 0.9 | 1.0 | 1.1 | 1.2 | 1.2 |
| UBT251用药患者群 | 亿人 | - | - | - | 0.004 | 0.01 | 0.02 | 0.04 | 0.03 | 0.02 | 0.02 | 0.01 |
| 单患者用药价格 | 美元/年 | - | - | - | 4650 | 4557 | 4420 | 4288 | 4073 | 3870 | 3676 | 3492 |
| yoy | % | - | - | - | - | -2.00% | -3.00% | -3.00% | -5.00% | -5.00% | -5.00% | -5.00% |
| 风险调整系数 | % | 50% | 50% | 50% | 50% | 50% | 50% | 50% | 50% | 50% | 50% | 50% |
| UBT251预计全球销售额 | 亿美元 | - | - | 8.25 | 17.19 | 45.99 | 85.47 | 70.68 | 40.70 | 42.29 | 21.20 |
| yoy | % | - | - | - | 108.45% | 167.55% | 85.85% | -17.31% | -42.42% | 3.91% | -49.86% |
| 销售分成 | % | - | - | - | 5.00% | 8.00% | 10.00% | 12.00% | 12.00% | 8.00% | 5.00% | 5.00% |
| 基于销售额的分级特许权使用费 | 亿美元 | - | - | - | 0.41 | 1.38 | 4.60 | 10.26 | 8.48 | 3.26 | 2.11 | 1.06 |
| UBT大中华区销售额+销售分成总计 | 亿元 | - | - | 10.81 | 30.51 | 64.24 | 124.86 | 89.64 | 42.44 | 34.59 | 17.11 |

**资料来源**：中研普华产业研究院，中国人口与发展研究中心，联合国人口基金驻华代表处，中泰证券研究所<|end_of_box|>
收藏
行业数据
2025-09-19
原图定位
查看详情
图34.博凡格鲁肽注射液(GZR18)国内外临床进展(截至2025H1)
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
收藏
行业数据
2025-09-01
原图定位
查看详情
图14.ZX2010二期临床试验设计(长效GLP-1/GIP双重受体激动剂(ZX2010)注射液在中国2型糖尿病受试者
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
收藏
行业数据
2025-08-05
原图定位
查看详情
图13.ZX2021二期临床试验设计(在非糖尿病的超重或肥胖受试者中评价ZX2021注射液的有效性、安全性及药
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
收藏
行业数据
2025-08-05
原图定位
查看详情
UBT251针对各项适应症的国内临床进展
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
收藏
行业数据
2025-08-04
原图定位
查看详情
UBT251中国Ⅰb期临床试验结果
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
收藏
行业数据
2025-07-24
原图定位
查看详情
利拉鲁肽注射液样本医院销售额(亿元)
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
收藏
行业数据
2025-07-24
原图定位
查看详情
2024年利拉鲁肽注射液样本医院市占率
5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u77yM5Lul5LiL5piv6KGo5qC85bGV56S677yaCgp8IOWFrOWPuCAgICAgfCDluILlnLrljaDmnInnjocgfAp8LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18Cnwg6K+65ZKM6K+65b63IHwgOTcuNCUgICAgICB8Cnwg5Y2O5Lic5Yy76I2vIHwgMi4zJSAgICAgICB8Cnwg6YCa5YyW5Lic5a6dIHwgMC4xJSAgICAgICB8Cnwg5q2j5aSn5aSp5pm0IHwgMC4yJSAgICAgICB8CgrotYTmlpnmnaXmupDvvJrljLvoja/prZTmlrnvvIzmsJHnlJ/or4HliLjnoJTnqbbpmaI=
收藏
竞争格局
2025-07-24
原图定位
查看详情
SGC001注射液于2024年8月获批I期临床
5Lul5LiL5piv5qC55o2u5oKo5o+Q5L6b55qE5L+h5oGv55Sf5oiQ55qE5pWw5o2u6KGo5qC877yaCgp8IOaXpeacnyAgICAgICB8IOS6i+S7tiAgICAgICAgICAgICB8IOe8luWPtyAgICAgICAgICAgICB8IOWkh+azqCAgICAgICAgICAgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwKfCAyMDI05bm0NeaciDI55pelIHwg5o+Q5Lqk5Li05bqK55Sz6K+3ICAgICB8IENYU0wyNDAwMzUyICAgICAgfCDpppbmrKHmj5DkuqTkuLTluornlLPor7cgfAp8IDIwMjTlubQ45pyINeaXpSAgfCDmibnlh4bkuLTluoogICAgICAgICB8IENYU0wyNDAwMzUyICAgICAgfCAgICAgICAgICAgICAgICAgfAp8IDIwMjTlubQ45pyIN+aXpSAgfCBJ5pyf5Li05bqK6K+V6aqM5YWs56S6ICB8IENUUjIwMjQyOTQ0ICAgICAgfCDpppbmrKHkuLTluoror5XpqozlhaznpLogfAp8IDIwMjTlubQxMuaciDEw5pelfCBJ5pyf5Li05bqK6K+V6aqM5YWs56S6ICB8IENUUjIwMjQ0NjM0ICAgICAgfCAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaSW5zaWdodCDmlbDmja7lupM=
收藏
行业数据
2025-07-15
原图定位
查看详情
UBT-251减重适应症国内峰值测算
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
收藏
行业数据
2025-07-14
原图定位
查看详情
联邦生物与诺和诺德达成UBT251海外授权合作
fCDmnYPnm4rojIPlm7QgfCDotKLliqHmnaHmrL4gfAp8LS0tLS0tLS0tLXwtLS0tLS0tLS0tfAp8IOiBlOmCpueUn+eJqeS/neeVmeWkp+S4reWNjuWMuuadg+WIqSB8IOmmluS7mOasviAy5Lq/576O5YWDIHwKfCDor7rlkozor7rlvrfpmaTlpKfkuK3ljY7ljLrlhajnkIPni6zlrrbmjojmnYPorrjlj6/lvIDlj5HjgIHnlJ/kuqfjgIHllYbkuJrljJYgfCDph4znqIvnopHku5jmrL7mnIDpq5jovr4xOOS6v+e+juWFgyB8CnwgICAgICAgICAgfCDln7rkuo7lh4DplIDllK7pop3nmoTliIbnuqfnibnorrjmnYPkvb/nlKjotLkgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45Lia57up5bGV56S65p2Q5paZ
收藏
行业数据
2025-07-10
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
三靶点药物在减重 率、最终减重 果上均有优势,UBT251 临床 Ib 期 优异。通过对比不同靶点 GLP-1 注射剂药物减重 果,礼来的 GLP-1R/GIPR/GCGR 三靶点产品 Retatrutide在 12mg QW剂量组在第 48周实现减重约 24%的优秀 ,彰显出 GLP-1R/GIPR/GCGR 三靶点产品在减重适应症上巨大的临床潜力。而联邦同类产品 UBT251 在饮食诱导肥胖小鼠减重果与礼来 Retatrutide 相比展现出优势, 显示在低剂量用药 ,UBT251较 Retatrutide展现出更强的减重 果且起 更快。UBT251的 Ib期 显示,给药第 12 周,最高剂量组平均体重较基线下降 15.1%,优于礼来 Retatrutide 同期 ,对标安慰剂调 后达到 16.6%,减重 优异;安全性 面,UBT251的安全性特征与其他肠促胰岛素类产品相似,最常见的不良事件为胃肠道反应,且绝大多 为轻度至中度。
行业数据
原图定位
当前图表所属:
联邦制药(3933.HK)-港股公司研究报告:UBT251海外授权彰显研发成果创新管线打开成长天花板-250801(30页).pdf
可比公司估值对比分析(单位:亿元人民币)
公司各业务板块入预测及拆分(单位:亿元人民币)
公司胰岛素首次及续约集采中标情况对比
动保产能基地建设进度
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》